Cite
MLA Citation
Helmut Butzkueven et al.. “Natalizumab versus fingolimod for patients with active relapsing-remitting multiple sclerosis: results from REVEAL, a prospective, randomised head-to-head study.” BMJ open, vol. 10, no. 10, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127576888.0x000040